These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27165202)

  • 21. Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women.
    Ghisari M; Eiberg H; Long M; Bonefeld-Jørgensen EC
    Environ Health; 2014 Mar; 13(1):19. PubMed ID: 24629213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women.
    Sangrajrang S; Sato Y; Sakamoto H; Ohnami S; Laird NM; Khuhaprema T; Brennan P; Boffetta P; Yoshida T
    Int J Cancer; 2009 Aug; 125(4):837-43. PubMed ID: 19415745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity.
    Berstein LM; Imyanitov EN; Kovalevskij AJ; Maximov SJ; Vasilyev DA; Buslov KG; Sokolenko AP; Iyevleva AG; Chekmariova EV; Thijssen JH
    Cancer Lett; 2004 Apr; 207(2):191-6. PubMed ID: 15072828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer risk.
    Miyoshi Y; Ando A; Hasegawa S; Ishitobi M; Yamamura J; Irahara N; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Eur J Cancer; 2003 Nov; 39(17):2531-7. PubMed ID: 14602139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study.
    Antognelli C; Del Buono C; Ludovini V; Gori S; Talesa VN; Crinò L; Barberini F; Rulli A
    BMC Cancer; 2009 Apr; 9():115. PubMed ID: 19379515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYP19 gene polymorphisms and the susceptibility to breast cancer in Xinjiang Uigur women.
    Yang L; Wang XY; Li YT; Wang HL; Wu T; Wang B; Zhao Q; Jinsihan D; Zhu LP
    Genet Mol Res; 2015 Jul; 14(3):8473-82. PubMed ID: 26345775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients.
    Fasching PA; Loehberg CR; Strissel PL; Lux MP; Bani MR; Schrauder M; Geiler S; Ringleff K; Oeser S; Weihbrecht S; Schulz-Wendtland R; Hartmann A; Beckmann MW; Strick R
    Breast Cancer Res Treat; 2008 Nov; 112(1):89-98. PubMed ID: 18049890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of association between the functional polymorphisms in the estrogen-metabolizing genes and risk for hepatocellular carcinoma.
    Yuan X; Zhou G; Zhai Y; Xie W; Cui Y; Cao J; Zhi L; Zhang H; Yang H; Zhang X; Qiu W; Peng Y; Zhang X; Yu L; Xia X; He F
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3621-7. PubMed ID: 19064581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of serum sex steroid levels and bone mineral density with CYP17 and CYP19 gene polymorphisms in postmenopausal women in Turkey.
    Yilmaz MB; Pazarbasi A; Guzel AI; Kocaturk-Sel S; Kasap H; Kasap M; Urunsak IF; Basaran S; Alptekin D; Demirhan O
    Genet Mol Res; 2011 Sep; 10(3):1999-2008. PubMed ID: 21948762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of CYP2C19*2 (rs4244285) and CYP17 (rs743572) SNPs on Adriamycin and Paclitaxel based Chemotherapy Outcomes in Breast Cancer Patients.
    Gudur RA; Bhosale SJ; Gudur AK; Kale SR; More AL; Datkhile KD
    Asian Pac J Cancer Prev; 2024 Jun; 25(6):1977-1986. PubMed ID: 38918659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study.
    Ahsan H; Whittemore AS; Chen Y; Senie RT; Hamilton SP; Wang Q; Gurvich I; Santella RM
    Breast Cancer Res; 2005; 7(1):R71-81. PubMed ID: 15642171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variants in CYP17 and CYP19 cytochrome P450 genes are associated with onset of Alzheimer's disease in women with down syndrome.
    Chace C; Pang D; Weng C; Temkin A; Lax S; Silverman W; Zigman W; Ferin M; Lee JH; Tycko B; Schupf N
    J Alzheimers Dis; 2012; 28(3):601-12. PubMed ID: 22057025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP17 and SULT1A1 gene polymorphisms in Indian breast cancer.
    Chacko P; Rajan B; Mathew BS; Joseph T; Pillai MR
    Breast Cancer; 2004; 11(4):380-8. PubMed ID: 15604994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.
    Verla-Tebit E; Wang-Gohrke S; Chang-Claude J
    Breast Cancer Res; 2005; 7(4):R455-64. PubMed ID: 15987450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women.
    Miyoshi Y; Noguchi S
    Biomed Pharmacother; 2003 Dec; 57(10):471-81. PubMed ID: 14637391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steroid metabolism gene polymorphisms and their implications on breast and ovarian cancer prognosis.
    Dos Santos EVW; Alves LNR; Louro ID
    Genet Mol Res; 2017 Jul; 16(3):. PubMed ID: 28692125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying susceptibility genes for prostate cancer--a family-based association study of polymorphisms in CYP17, CYP19, CYP11A1, and LH-beta.
    Douglas JA; Zuhlke KA; Beebe-Dimmer J; Levin AM; Gruber SB; Wood DP; Cooney KA
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2035-9. PubMed ID: 16103457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYP1A1, GSTM1, GSTT1 and TP53 Polymorphisms and Risk of Gallbladder Cancer in Bolivians.
    Sakai K; Loza E; Roig GV; Nozaki R; Asai T; Ikoma T; Tsuchiya Y; Kiyohara C; Yamamoto M; Nakamura K
    Asian Pac J Cancer Prev; 2016; 17(2):781-4. PubMed ID: 26925680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic polymorphism of estrogen metabolizing enzymes in Siberian women with breast cancer.
    Khvostova EP; Pustylnyak VO; Gulyaeva LF
    Genet Test Mol Biomarkers; 2012 Mar; 16(3):167-73. PubMed ID: 21977969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.